PAMU
TRIL

Pictet Asset Management (UK)’s Trillium Therapeutics Inc. TRIL Stock Holding History

Pictet Asset Management (UK)’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$23.2M Buy
2,388,417
+1,362,153
+133% +$12.8M 0.03% 494
2021
Q1 		$11M Hold
1,026,264
– – 0.01% 638
2020
Q4 		$15.1M Buy
+1,026,264
New +$14.8M 0.02% 537

Other funds holding TRIL

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Pictet Asset Management (UK)'s TRIL Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Trillium Therapeutics Inc. (TRIL) stake by 133% in Q2 2021, buying an estimated $12.8M and bringing the position to 2,388,417 shares worth $23.2M. The position accounts for 0.03% of the portfolio, ranked #494.

Pictet Asset Management (UK) first reported a position in TRIL in Q4 2020 and has held it in 3 quarters since. 137 funds tracked by Wall St. Rank hold TRIL as of Q2 2021.

  • Pictet Asset Management (UK) held 2,388,417 shares of Trillium Therapeutics Inc. worth $23.2M as of Q2 2021.
  • Pictet Asset Management (UK) bought 1,362,153 Trillium Therapeutics Inc. shares in Q2 2021, an estimated $12.8M.
  • Trillium Therapeutics Inc. made up 0.03% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #494 holding.
  • Pictet Asset Management (UK) first reported a position in Trillium Therapeutics Inc. in Q4 2020 and has held it in 3 quarters since.
  • 137 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.